secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001193125-25-260863
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours adopts new executive severance policy with 2.0x multiplier for CEO
---------------------------------------------------------------------------

- CEO severance: 2.0x sum of base salary, target annual incentive, and annualized health care subsidy; other execs 1.0x.
- Payable on involuntary termination without Cause or resignation for Good Reason; requires signed release of claims.
- Existing change-in-control agreements and equity award terms remain in effect; policy does not supersede them.
- Policy effective October 28, 2025; administered by Board or Compensation Committee; amendment requires 12-month notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/0001193125-25-260863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/cc-20251028.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-260863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer